Rating History for Lineage Cell Therapeutics Inc. (LCTX) by Canaccord

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/28/2026 John Newman New Coverage Buy
(N/A)
9.00
(N/A)
1.55
(1.26)
-18.71% Details